
EoE extends beyond eosinophilic inflammation, with epithelial barrier dysfunction helping perpetuate disease activity. Recognizing how patients adapt to chronic symptoms may be equally important for identifying disease earlier.
Gastroenterology experts discuss eosinophilic esophagitis as a chronic, progressive disease, covering earlier recognition, endoscopic and biopsy best practices, individualized treatment selection with topical steroids and biologics, new long-term and phase 4 data, strategies for access and persistence, pediatric transition, and emerging therapeutic targets for sustained disease control.

EoE extends beyond eosinophilic inflammation, with epithelial barrier dysfunction helping perpetuate disease activity. Recognizing how patients adapt to chronic symptoms may be equally important for identifying disease earlier.

Early EoE recognition depends on looking beyond overt dysphagia and performing an adequate diagnostic evaluation. Careful endoscopy and appropriately distributed biopsies can prevent missed opportunities for diagnosis.